2001, Food and Drug Administration and Prescription

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2001

Food and Drug Administration

Prescription

Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years

Pharmaceutical Technology

JUNE 29, 2022

The US Food and Drug Administration (FDA) put a high-profile bluebird bio trial for sickle cell disease on partial clinical hold, and advisory panels deliberated over decisions involving gene therapies for amyotrophic lateral sclerosis (ALS), cerebral adrenoleukodystrophy (CALD), and beta-thalassemia.

Food and Drug Administration

Food and Drug Administration FDA Marketing Pharmaceutical

Psychedelic medicines: are they gaining traction in Europe?

European Pharmaceutical Review

APRIL 13, 2023

As psychedelics diffused into wider society and recreational use increased, some individuals reported…ongoing symptoms after the drugs had left the body” At a time when psychiatry lacked effective medical therapies, the discovery of LSD was of interest.

Medicine

Medicine Food and Drug Administration Doctors Government

Pharma Rep Focus

Rare Disease Spotlight – tracing the rise of orphan drug designations over almost 40 years

Psychedelic medicines: are they gaining traction in Europe?

Stay Connected